Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. - sprookjes - yvandenbroek - TriplyDB

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

http://www.wikidata.org/entity/Q33855709

about

Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships Emerging strategies of bone and joint repair.Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies?Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?Non-Hematopoietic Essential Functions of Bone Marrow Cells: A Review of Scientific and Clinical Literature and Rationale for Treating Bone Defects Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy The multi-differentiation potential of peripheral blood mononuclear cells The role of stem cells in fracture healing and nonunion Mesenchymal stem cell transplantation in multiple sclerosis Mesenchymal stem cells migration homing and tracking Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses Degenerate wave and capacitive coupling increase human MSC invasion and proliferation while reducing cytotoxicity in an in vitro wound healing model Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells Clinical applications of mesenchymal stem cells in chronic diseases.Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells Physiologic predictors of lumbar spine bone mass in neonates.Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis.Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo.Hematopoietic potential of stem cells isolated from murine skeletal muscle Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia.Stem cell treatment for complicated diabetes.Current status of cell therapies in stroke.

P2860

Q24298392-43E2BD42-786F-4381-B94C-00310DD37229 Q24632544-7B188FE1-2FD6-4670-9E6F-F01F8FF0CA2B Q24635138-620316AD-7553-4D5E-BA5C-CB1CBD16BAA9 Q24655456-44B42686-9FA1-4BDA-9A80-F9982C338901 Q24805068-C14545AB-FF73-49D1-9D72-F793A15711BD Q24812198-D462C406-E1D1-4EFA-9C0F-0215CE46A27B Q26745898-97C85104-1517-4F23-B30F-7E68EE849AD7 Q26752205-A96B391F-ACCC-4818-88CB-D95BA230DF14 Q26753086-B2511823-8FA4-437E-88C7-BD5F837E260D Q26766574-5FEA059D-6F54-4BCF-94ED-9BF0B62897E3 Q26770338-B626893C-B2D8-48C2-9BB6-E9DD3012CE4A Q26774850-F4F0E19A-A65D-4680-838C-AF80DA2C790B Q26801575-B963BAF0-203F-4A62-A6E1-C59041732C94 Q26825272-710BD6EA-E63B-4A61-BD2D-7FE21BBE9DD4 Q26852323-DA40B5E0-64C9-4AFB-ACA7-BDE97D784086 Q26859369-CFD8EDB3-2D16-4E44-AC9B-251EE68D6A19 Q26999783-A214A072-5825-429B-835A-B97EFE162DB5 Q27003059-E0E3C4A6-701A-41B2-81C8-4EB2AC0EFDA5 Q27321287-B0AFBC29-3756-4BFE-8F0D-85B04C68BEE6 Q28069791-40597DEE-3A73-4275-98FF-AF185E51B69B Q28082334-F918E584-D906-4AF4-9EF1-4480F8AA7791 Q28251644-874AAD0B-633F-4C96-B19D-FAEDEFA969DC Q28534582-760FE9A4-648D-4606-9716-B0807AABD0BB Q28741379-9073C89D-8F7E-4178-92E1-1E8144DDB914 Q29620590-5096E802-4BBE-4E5E-833E-11C5DB44B2FA Q30009860-259890DB-8C9D-4039-A318-14022FFC8F93 Q30160229-9089ECB2-B646-4D58-9074-E2810857CD9A Q30415068-05A61C51-6616-41C8-9181-8D0DBEE47FCD Q30437823-D274899F-3512-49EC-A92F-45BB319CB05F Q30454202-47A1E511-74DE-4798-AE91-6C1D3B9A6E21 Q30928424-B9BA3A9C-3C08-46B9-A18B-76E10A3F3E73 Q30942028-94FF4DD5-AF57-4085-B7A8-9FA660521704 Q31133087-80670712-E07A-406A-BDCE-3054FAF3FC8E Q31909374-3AA8413D-6E01-4E35-84AE-562C5C03ECB8 Q33179264-E1AA9CB0-3692-40FB-906F-59EB90FD85C2 Q33378960-9605278F-8DB1-4E9A-AB0D-EEC3CC355D78 Q33494039-7CD8144A-8020-4D97-B55C-780E3C2A8165 Q33575009-9A7FADDB-FEEC-4C5B-AF5D-6C047ECEB456 Q33614750-B612200E-12B1-47CB-BA6B-406B2B6A3489 Q33614825-EF61A240-69FD-4ACF-AAA1-CEB3CA7606A6

P2860

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

http://www.wikidata.org/entity/Q33855709

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Transplantability and therapeu ...... with osteogenesis imperfecta.

@ast

Transplantability and therapeu ...... with osteogenesis imperfecta.

@en

type

label

Transplantability and therapeu ...... with osteogenesis imperfecta.

@ast

Transplantability and therapeu ...... with osteogenesis imperfecta.

@en

prefLabel

Transplantability and therapeu ...... with osteogenesis imperfecta.

@ast

Transplantability and therapeu ...... with osteogenesis imperfecta.

@en

P1433

Q33855709-5AA205ED-004F-4828-869E-5C47577A9DB3

P1476

Q33855709-2E1293E4-8A51-43FB-AD22-B2F81919A4AE

P2093

Q33855709-07C46932-A4EA-4700-BDC3-2FA09F76FBAF

Q33855709-262DA4BD-4B5F-45EB-B036-B170BFA2035F

Q33855709-3C24EEB2-1D50-4476-89CD-E8A3719F4B2C

Q33855709-69B58229-7F93-4267-A9E7-2C491ACBE8D4

Q33855709-7A5B4BE8-B467-413B-A8BA-ADB7A5C836C0

Q33855709-A70BEF47-F1B0-4F05-AE81-2013B7B944BF

Q33855709-CB570CA4-9172-4E6A-AB9B-D2C99830DB61

Q33855709-CE1952E5-CB46-4C6F-958E-5D475CB84632

Q33855709-CE1FCF91-2C54-4D78-954E-3A8CA8B1298D

Q33855709-D52CDF57-5337-4A89-B9B6-5154FAF695C2

P2888

Q33855709-BBD418F3-0FE1-4590-BD2C-FF35B96F97D8

P304

Q33855709-7DA64BCF-35C9-41C3-8A29-B5561D615EB7

P31

Q33855709-ADCE7844-042C-4527-B2E3-0DC76B37E640

P356

Q33855709-D12190A3-947B-4373-8FA2-34BAB2810933

P407

Q33855709-5C27109D-1A50-476D-A86C-C5E2DA932DF5

P433

Q33855709-EC634EEE-BA33-4C04-AEEE-DD499895FC0C

P478

Q33855709-04AC4D3B-25A1-414D-92D6-D334F4C02448

P577

Q33855709-509EB0A9-4137-496A-9DDD-1FAE8C3C75B7

P5875

Q33855709-3DB488F6-558C-4C83-9705-99B668DA6C51

P698

Q33855709-E63BC586-2B3B-4E9B-9044-C69568C9A6BE

P921

Q33855709-51488D23-C383-476F-86F4-3E06BFDC087B

Q33855709-BB75BED9-36D5-49CC-A3F2-6EB11DE10052

P356

P1433

Nature Medicine

P1476

Transplantability and therapeu ...... with osteogenesis imperfecta.

@en

P2093

Brenner MK

http://www.w3.org/2001/XMLSchema#string

Fitzpatrick LA

http://www.w3.org/2001/XMLSchema#string

Gordon PL

http://www.w3.org/2001/XMLSchema#string

Horwitz EM

http://www.w3.org/2001/XMLSchema#string

Koo WW

http://www.w3.org/2001/XMLSchema#string

Marx JC

http://www.w3.org/2001/XMLSchema#string

Neel M

http://www.w3.org/2001/XMLSchema#string

Orchard P

http://www.w3.org/2001/XMLSchema#string

Prockop DJ

http://www.w3.org/2001/XMLSchema#string

Pyeritz RE

http://www.w3.org/2001/XMLSchema#string

P2888

P304

309-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/6529

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13205475

http://www.w3.org/2001/XMLSchema#string

P698

10086387

http://www.w3.org/2001/XMLSchema#string

P921

osteogenesis imperfecta